PTX3 and periodontitis: As shown in Table 4, most assessed parameters (clinical and immunological) showed a similar evolution in the groups of patients with periodontitis (HCV+P and P), from baseline to recall, apart from the GCF PTX3 parameter, which expressed a more important decrease in P group (−43.75%), than in the HCV+P one (−39.47%).